glaxosmithkline plc (GSK:London)
Robert Peter Wilson KCMG
Independent Non-Executive Director, Member of Corporate Administration & Transactions Committee, Member of Audit & Risk Committee, Member of Finance Committee, Member of Nominations Committee and Member of Corporate Responsibility Committee, GlaxoSmithKline plc
|Age||Total Calculated Compensation||This person is connected to 71 board members in 3 different organizations across 10 different industries.|
See Board Relationships
Sir Robert Peter Wilson, KCMG served as the Chief Executive Officer of Rio Tinto PLC (formerly, RTZ) from 1991 to 1997. Sir Wilson joined Rio Tinto in 1970. He began his career since 1966 as an Economist with Dunlop Ltd. He was appointed Knight Commander in the order of St Michael and St George (KCMG) in 2000 for services to British interests overseas. He serves as Chairman of the Board of Rio Tinto Group. Sir Wilson served as the Non Executive Chairman at BG Group PLC ...
Corporate Headquarters*980 Great West Road
Brentford, Middlesex TW8 9GS
Phone: 44 20 8047 5000
Fax: 44 20 8047 7807
Board Members Memberships*
Former Director and Executive Chairman of Rio Tinto Limited
Former Non Executive Director
Former Executive Chairman
Former Senior Non Executive Director
Former Non-Executive Director, Chairman of Finance Committee, Chairman of Nominations Committee, Chairman of Chairmans Committee, Member of Remuneration Committee and Member of Sustainability Committee
Former Non-Executive Chairman
Former Chairman of Remuneration Committee and Member of Audit Committee
Independent Non-Executive Director, Member of Corporate Administration & Transactions Committee, Member of Audit & Risk Committee, Member of Finance Committee, Member of Nominations Committee and Member of Corporate Responsibility Committee
Honorary Doctorate 2001
University Of Dundee
Honorary Doctorate 1993
Harvard Business School
University of Sussex
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|John C. Martin Ph.D.||Chairman and Chief Executive Officer|
Gilead Sciences Inc.
|Marijn E. Dekkers Ph.D.||Chairman of Management Board and Chief Executive Officer|
|Kenneth C. Frazier||Chairman, Chief Executive Officer and President|
Merck & Co. Inc.
|Christopher A. Viehbacher||Chief Executive Officer, Director and Member of Strategy Committee|
|Severin Schwan||Chief Executive Officer and Director|
Roche Holding AG
|SFr.6.5M||Compensation as of Fiscal Year 2012.|